Change in Antithyroglobulin Antibody Levels is a Good Predictor of Responses to Therapy in Antithyroglobulin Antibody-Positive Pediatric Papillary Thyroid Carcinoma Patients

OBJECTIVE: Antithyroglobulin antibodies (TgAbs) could be used as a surrogate tumor marker of TgAb-positive-differentiated thyroid carcinoma. This study aims to determine whether the change in TgAb levels over time could be used as a predictor of responses to therapy in pediatric papillary thyroid ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Xi, Chuang, Zhang, Guo-Qiang, Song, Hong-Jun, Shen, Chen-Tian, Hou, Li-Ying, Qiu, Zhong-Ling, Luo, Quan-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930237/
https://www.ncbi.nlm.nih.gov/pubmed/35311033
http://dx.doi.org/10.1155/2022/7173919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930237/
https://www.ncbi.nlm.nih.gov/pubmed/35311033
http://dx.doi.org/10.1155/2022/7173919

Ejemplares similares